MARGARET MACY, MD
Medical Practice at 16 Ave, Denver, CO

License number
Colorado 42587
Category
Medical Practice
Type
Pediatric Hematology-Oncology
Address
Address
13123 E 16Th Ave, Denver, CO 80045
Phone
(720) 777-1234
(303) 493-7000

Organization information

See more information about MARGARET MACY at bizstanding.com

Margaret Macy MD

13123 E 16 Ave, Aurora, CO 80045

Industry:
Pediatric Oncologist, Pediatrician
Phone:
(720) 777-6740 (Phone)
Margaret Ellen Macy

Professional information

Margaret Macy Photo 1

Margaret Macy, Aurora CO

Specialties:
Pediatric Hematologist / Oncologist
Address:
13123 E 16Th Ave, Aurora, CO 80045
Education:
Case Western Reserve University, School of Medicine - Doctor of Medicine
Board certifications:
American Board of Pediatrics Certification in Pediatrics, American Board of Pediatrics Sub-certificate in Pediatric Hematology/Oncology (Pediatrics)


Margaret E Macy Photo 2

Dr. Margaret E Macy, Aurora CO - MD (Doctor of Medicine)

Age:
50
Address:
13123 E 16 Ave, Aurora 80045
(720) 777-6740 (Phone)
7720 S Broadway STE 1, Littleton 80122
(720) 777-6740 (Phone)
Hospitals:
13123 E 16 Ave, Aurora 80045
7720 S Broadway STE 1, Littleton 80122
University Hospital
234 Goodman St, Cincinnati 45219
Education:
Medical Schools
Case Western Reserve University School Of Medicine
Graduated: 2002


Margaret Macy Photo 3

Methods Of Leukemia Cell Detection

US Patent:
2012006, Mar 15, 2012
Filed:
Apr 19, 2010
Appl. No.:
13/264943
Inventors:
Lia Gore - Denver CO, US
Deborah Deryckere - Boulder CO, US
Margaret E. Macy - Denver CO, US
Natalie Serkova - Denver CO, US
Assignee:
THE REGENTS OF THE UNIVERSITY OF COLORADO, A BODY CORPORATE - Denver CO
International Classification:
A61K 49/06, A61K 47/00, C12Q 1/02
US Classification:
424 93, 435 29, 514789
Abstract:
Methods are provided for, inter alia, determining the presence of leukemia cells in a subject, determining the change or potential change in the number of leukemia cells in the subject with time, determining whether a tissue in a subject contains a plurality of leukemia cells or a plurality progenitor leukemia cells, and determining whether a leukemia therapy administered to a subject is capable of decreasing the number of leukemia cells in a tissue of the subject.